FORT MYERS — NeoGenomics says it plans to sell 7 million shares in a secondary offering to raise $32.2 million to fund its growth, the company says in securities filings.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition